Article 76 requires Member States to ensure that systems for compensation for any damage suffered by a subject resulting from participation in a clinical trial are in place in the form of insurance, guarantee or similar arrangement. Member States are entitled to operate a national indemnification mechanism for low-intervention clinical trials (or other-than-low-intervention trials where Member State law so provides).
The graph holds this control, the 0 it maps to, and the evidence behind each claim, over MCP and REST.